Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32750
Title: | Immune mediated colitis: a surgical perspective. | Austin Authors: | Le, Khang Duy Ricky;Choy, Kay-Tai ;Roth, Sara;Heriot, Alexander G;Kong, Joseph C H | Affiliation: | Department of General Surgical Specialties, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. Surgery Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Geelong Clinical School, Deakin University, Geelong, Victoria, Australia. |
Issue Date: | Jun-2023 | Date: | 2023 | Publication information: | ANZ Journal of Surgery 2023; 93(6) | Abstract: | This study aims to review and summarize the current up to date literature that explore the current treatment approaches to immune mediated colitis and the role of surgical specialties in the landscape of management. A narrative review of papers was performed following a literature search through Medline, EMBASE and Cochrane Central databases pertaining to immune mediated colitis as an adverse event of cancer immunotherapy. Current guidelines for the diagnosis and treatment of immune mediated colitis mirror the approach to the workup of inflammatory bowel disease and guided by treating oncology and gastroenterology specialties. Immune mediated colitis however relies on surgical specific skills as a consequence of obtaining a diagnosis as well as in the management of complications that may arise. Immune mediate colitis management has largely been under the purview of medical specialties. This review explores the current landscape of managing immune mediated colitis from a surgical perspective and highlights key areas in which surgeons can engage in the multidisciplinary care of this condition. To facilitate prompt diagnosis and management of immune-mediated colitis, there is an increasing necessity for surgeons to become familiar with the latest multidisciplinary approaches and recommendations. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32750 | DOI: | 10.1111/ans.18485 | ORCID: | 0000-0003-4532-8248 0000-0001-5763-5742 0000-0001-9846-8776 0000-0002-1392-2480 |
Journal: | ANZ Journal of Surgery | PubMed URL: | 37088921 | ISSN: | 1445-2197 | Type: | Journal Article | Subjects: | checkpoint inhibitor induced colitis checkpoint inhibitors colon cytotoxic T-lymphocyte associated antigen 4 immune checkpoint inhibitors immune mediated colitis immune related adverse events immune therapy immunotherapy immunotherapy induced colitis programmed cell death protein 1 programmed death ligand 1 |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.